Indication
Details coming soon
Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Chronic Obstructive Pulmonary Disease |
Dose: Inhalation – 25 mcg/100 mcg (1 actuation) Frequency: once daily Note: Administered by mouth (oral inhalation) for long-term, once-daily, maintenance treatment of airflow obstruction with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema; also approved to reduce chronic obstructive pulmonary disease exacerbations. Hepatic impairment: No dosage adjustment required. |
|
Indication: Asthma Condition: patients not adequately controlled on a long-term asthma control medication (e.g., inhaled corticosteroid), or whose disease severity clearly warrants initiation of treatment with both an inhaled corticosteroid and a long-acting beta agonist (LABA) |
Dose: Inhalation – 25 mcg/100 mcg or 25 mcg/200 mcg per actuation Frequency: once daily Note: Administered via oral inhalation. Hepatic impairment: No dosage adjustment required. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Asthma Age: 5 to 11 years |
Dose: Oral inhalation – 50 mcg fluticasone furoate and 25 mcg vilanterol (1 inhalation) Frequency: once daily |
|
Indication: Asthma Age: 12 to 17 years |
Dose: Oral inhalation – 100 mcg fluticasone furoate and 25 mcg vilanterol (1 inhalation) Frequency: once daily Note: maximum dose: 1 inhalation in 24 hours |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Not mentioned Note: Renal impairment: No dosage adjustment required |
Administration
- Take at same time each day
- Rinse mouth after use
Side Effect
- Nasopharyngitis (9%)
- Upper respiratory infection (7%)
- Headache (7%)
- Oropharyngeal candidiasis (5%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
β-adrenergic blockers
|
Weakened or antagonized effect
|
|
Strong CYP3A4 inhibitors (e.g. ketoconazole, ritonavir)
|
Increased systemic exposure
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Status Asthmaticus, Acute Episodes of COPD
|
Not for emergency treatment
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.